Literature DB >> 10885836

Helicobacter pylori--a trigger of reactive arthritis?

K K Melby1, T K Kvien, A Glennås.   

Abstract

Four cases of reactive arthritis (ReA) related to Helicobacter pylori (HP) are presented. These were identified by IgG, IgM and IgA ELISA tests performed on sera obtained from a 2-year prospective study on 186 patients with a clinical picture suggesting ReA as a possible diagnosis. If anti-HP IgM and IgA or IgG were positive, the case was considered related to HP. Three out of four HP ReA patients were originally classified as "possible ReA", i.e. having a clinical picture of ReA but without any identified triggering microorganism. IgG antibodies against cagA and vacA were detected in three and two cases respectively. The HP ReA patients did not present with typical clinical or laboratory features differentiating them from ReA induced by Chlamydia trachomatis (N = 25) or enteropathogenic bacteria (N = 27). However, compared to findings in patients with ReA due to enteropathogenic bacteria the number of active joints was higher (six versus two), duration of arthritis longer (3.9 weeks versus 2 weeks) and the CRP (C-reactive protein) lower (43 versus 59). Our findings suggest that HP may be included in the list of possible arthritis triggering microbes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10885836     DOI: 10.1007/s150100050022

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  4 in total

Review 1.  Reactive arthritis or chronic infectious arthritis?

Authors:  J Sibilia; F-X Limbach
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

2.  Toxic epidermal necrolysis induced by a triple-drug regimen for helicobacter pylori eradication.

Authors:  Yoshihiro Matsukawa; Hiroyuki Hara; Masanori Aoki; Kentaro Inada; Motohide Kaneko; Ko Mitamura; Umihiko Sawada; Shigemasa Sawada; Takashi Horie; Toyoko Ochiai
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

3.  Treating reactive arthritis: insights for the clinician.

Authors:  John D Carter
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-02       Impact factor: 5.346

4.  Multi-omic landscape of rheumatoid arthritis: re-evaluation of drug adverse effects.

Authors:  Paolo Tieri; XiaoYuan Zhou; Lisha Zhu; Christine Nardini
Journal:  Front Cell Dev Biol       Date:  2014-11-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.